In the largest study to date exploring the relationship between severe psoriasis and coronary microvascular dysfunction, researchers have found further evidence that patients with severe psoriasis are at higher cardiovascular risk.
UK point-of-care production of cell therapies could arrive in 2025
The UK government is proposing to allow groundbreaking manufacturing methods that would permit cell therapies to be made at the patient’s point of care (POC).
November 22, 2024